Somatostatin analogue treatment for malignant hypercalcaemia
BMJ
.
1990 May 19;300(6735):1313-4.
doi: 10.1136/bmj.300.6735.1313-a.
Authors
M Harrison
1
,
N James
,
K Broadley
,
S R Bloom
,
R Armour
,
S Wimalawansa
,
D Heath
,
J Waxman
Affiliation
1
Department of Clinical Oncology, Hammersmith Hospital, London.
PMID:
2369665
PMCID:
PMC1663053
DOI:
10.1136/bmj.300.6735.1313-a
No abstract available
Publication types
Case Reports
MeSH terms
Adrenal Gland Neoplasms / complications
Dose-Response Relationship, Drug
Humans
Hypercalcemia / drug therapy*
Hypercalcemia / etiology
Male
Middle Aged
Octreotide / therapeutic use*
Pheochromocytoma / complications
Substances
Octreotide